HOLX241220C95000
- 0.25
- 0.000.00%
Hologic Newsroom
Morgan Stanley Maintains Hologic(HOLX.US) With Hold Rating, Maintains Target Price $84
A Quick Look at Today's Ratings for Hologic(HOLX.US), With a Forecast Between $84 to $95
Hologic's Strategic Advancements and Robust Market Position Earns 'Buy' Rating Despite Conservative Outlook
Hologic Is Maintained at Overweight by JP Morgan
Hologic Analyst Ratings
Raymond James Adjusts Price Target on Hologic to $95 From $93, Maintains Outperform Rating
RBC Capital Maintains Hologic(HOLX.US) With Hold Rating, Raises Target Price to $89
Needham Maintains Hologic(HOLX.US) With Buy Rating, Maintains Target Price $90
Hologic's Strong Performance and Future Growth Prospects Justify Buy Rating
RBC Capital Maintains Hologic(HOLX.US) With Hold Rating, Raises Target Price to $86
RBC Capital Sticks to Its Hold Rating for Hologic (HOLX)
Morgan Stanley Maintains Hologic(HOLX.US) With Hold Rating, Maintains Target Price $84
J.P. Morgan Maintains Hologic(HOLX.US) With Buy Rating, Cuts Target Price to $92
Hologic Analyst Ratings
Needham Maintains Hologic(HOLX.US) With Buy Rating, Maintains Target Price $90
Hologic's Strategic Acquisition of Gynesonics Bolsters Market Position: A Buy Rating by Michael Matson
JPMorgan Adjusts Hologic Price Target to $92 From $95, Maintains Overweight Rating
Buy Rating Maintained for Hologic Amidst Recovery and Strong Capital Management
Hologic Price Target Cut to $90.00/Share From $95.00 by Leerink Partners
Mizuho Securities Maintains Hologic(HOLX.US) With Buy Rating, Raises Target Price to $90